Results 211 to 220 of about 25,027 (259)
Some of the next articles are maybe not open access.
Drug Intelligence & Clinical Pharmacy, 1984
Hypophosphatemia, defined as serum phosphate levels <2.5 mg%, is a relatively common disorder that can affect virtually every organ system. Phosphate deficiency can result from decreases in phosphate intake or absorption, increased loss from renal and nonrenal pathways, and transcellular phosphate shifts.
openaire +2 more sources
Hypophosphatemia, defined as serum phosphate levels <2.5 mg%, is a relatively common disorder that can affect virtually every organ system. Phosphate deficiency can result from decreases in phosphate intake or absorption, increased loss from renal and nonrenal pathways, and transcellular phosphate shifts.
openaire +2 more sources
Hypophosphatemia and Outcomes in ICU: A Systematic Review and Meta-Analysis
Journal of Intensive Care Medicine, 2020Purpose: Hypophosphatemia is reported in up to 5% of hospitalized patients and ranges from 20% to 80% in critically ill patients. The consequences of hypophosphatemia for critically ill patients remain controversial.
J. C. K. Sin +5 more
semanticscholar +1 more source
Hypophosphatemia-induced Cardiomyopathy
The American Journal of the Medical Sciences, 2016Relatively few studies have been conducted to evaluate the effect of hypophosphatemia on cardiac function. The goal of this review was to determine whether there is an association between hypophosphatemia and cardiac function and to increase awareness of hypophosphatemia-induced cardiomyopathy as a new clinical entity and a reversible cause of heart ...
Nobuhiro, Ariyoshi +4 more
openaire +2 more sources
Pediatric Nephrology, 2012
Over the last decade the discovery of fibroblast growth factor 23 (FGF23) and the progressive and ongoing clarification of its role in phosphate and mineral metabolism have led to expansion of the diagnostic spectrum of primary hypophosphatemic syndromes. This article focuses on the impairment of growth in these syndromes.
Fernando, Santos +5 more
openaire +2 more sources
Over the last decade the discovery of fibroblast growth factor 23 (FGF23) and the progressive and ongoing clarification of its role in phosphate and mineral metabolism have led to expansion of the diagnostic spectrum of primary hypophosphatemic syndromes. This article focuses on the impairment of growth in these syndromes.
Fernando, Santos +5 more
openaire +2 more sources
Archives of Internal Medicine, 1963
The etiology of rachitic bone disease associated with hypophosphatemia, which requires large doses of vitamin D for treatment, has been a subject of dispute. Albright, Butler, and Bloomberg 1 have attributed the syndrome to parathyroid hyperplasia secondary to calcium malabsorption, whereas Fanconi and Girardet 2 have proposed an intrinsic and primary ...
J E, WHITE +3 more
openaire +2 more sources
The etiology of rachitic bone disease associated with hypophosphatemia, which requires large doses of vitamin D for treatment, has been a subject of dispute. Albright, Butler, and Bloomberg 1 have attributed the syndrome to parathyroid hyperplasia secondary to calcium malabsorption, whereas Fanconi and Girardet 2 have proposed an intrinsic and primary ...
J E, WHITE +3 more
openaire +2 more sources
Hypophosphatemia: A Practical Guide to Evaluation and Management.
Endocrine Practice, 2022P. Tebben
semanticscholar +1 more source